Trump administration unwinds ex-FDA chief Makary's tenure as acting head Diamantas revisits drug decisions and puts his signature voucher program in doubt.
As the White House mulls a pick to lead the FDA, the Trump administration has been washing away the mark of former commissioner Marty Makary …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Acting FDA chief Diamantas tells DeGette two Makary-era journal articles, on CAR-T trials and a rare disease pathway, were not…
Marty Makary resigned as FDA commissioner Tuesday. The next commissioner will inherit the same punishing contradictions, and a…
The gastrointestinal surgeon’s tenure was marked by mass layoffs, persistent churn among senior leaders and policy fights.
Trump plans to fire FDA Commissioner Marty Makary amid mounting criticism over his handling of drug reviews, nicotine vapes and…
His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.
Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.
